Contineum Therapeutics Inc. Class ACTNM 13F holders, Q2 2024 (June 30) 49 holders
1 famous investor
$17.61 avg. 13F price*
At the end of Q2 2024 , 49 institutions reported holding Contineum Therapeutics Inc. Class A (CTNM) in their 13F filings. The largest holders were Montanova Capital, LLC ($36.2M), Johnson & Johnson ($34.9M) and Perceptive Advisors LLC ($27.6M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
Company Contineum Therapeutics Inc. Class A
CUSIP 21217B100
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q2 2024 Institutions Total Value New Positions 49 $229.2M Exits 0 $0
Ownership 49 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ Montanova Capital, LLC 1.48% New 2,053,334 $36.2M Johnson & Johnson 8.70% New 1,979,173 $34.9M Perceptive Advisors LLC 0.67% New 1,566,668 $27.6M Versant Venture Management, LLC 20.92% New 918,163 $16.2M Sectoral Asset Management Inc. 5.73% New 800,887 $14.1M HHLR Advisors, LTD. 0.29% New 669,337 $11.8M Franklin Resources Inc. 0.00% New 627,008 $11.0M Samsara Biocapital, LLC 2.17% New 588,817 $10.4M Vanguard Group Inc. 0.00% New 471,617 $8.3M Altium Capital Management LLC 3.14% New 429,340 $7.6M BlackRock Inc. 0.00% New 396,273 $7.0M FMR LLC 0.00% New 323,600 $5.7M Baker Bros. Advisors LP 0.07% New 312,500 $5.5M Casdin Capital, LLC 0.40% New 296,666 $5.2M Adage Capital Partners Gp, L.L.C. 0.01% New 295,000 $5.2M Polar Capital Holdings Plc 0.02% New 214,442 $3.8M Norges Bank 0.00% New 166,178 $2.9M Geode Capital Management, LLC 0.00% New 156,421 $2.8M Squarepoint Ops LLC 0.01% New 150,000 $2.6M Citadel Advisors 0.00% New 127,785 $2.3M State Street Corp. 0.00% New 91,806 $1.6M Saturn V Capital Management LP 0.48% New 72,831 $1.3M Driehaus Capital Management LLC 0.01% New 66,667 $1.2M Charles Schwab Investment Management Inc. 0.00% New 51,772 $912K Walleye Capital LLC 0.01% New 44,185 $778K Board of Trustees of The Leland Stanford Junior University 0.05% New 38,869 $684K Bank of New York Mellon Corp 0.00% New 20,232 $356K Northern Trust Corp. 0.00% New 19,377 $341K Morgan Stanley 0.00% New 11,860 $209K Invesco Ltd. 0.00% New 10,771 $190K Rhumbline Advisers 0.00% New 6,722 $118K New York State Common Retirement Fund 0.00% New 5,400 $95K Sandia Investment Management LP 0.11% New 5,000 $88K Bank of America Corp. 0.00% New 4,467 $79K Corebridge Financial, Inc. 0.00% — 3,735 $66K JPMorgan Chase & Co. 0.00% New 2,958 $52K Wells Fargo & Company 0.00% New 2,548 $45K Barclays PLC 0.00% New 2,383 $42K UBS Group AG 0.00% New 2,107 $37K Legal & General Group Plc 0.00% New 2,087 $37K MetLife Investment Management, LLC 0.00% New 1,926 $34K Citigroup Inc. 0.00% New 1,529 $27K STRS Ohio 0.00% New 1,300 $23K Royal Bank of Canada 0.00% New 752 $13K Ameritas Investment Partners, Inc. 0.00% New 680 $12K California State Teachers Retirement System 0.00% New 503 $9K BNP Paribas Financial Markets 0.00% New 500 $9K Amalgamated Bank 0.00% New 240 $4K Tower Research Capital LLC (TRC) 0.00% New 94 $2K
"% of holder's portfolio" is CTNM's weight in each manager's 13F, not the share of Contineum Therapeutics Inc. Class A the manager owns.